[Surgical treatment of patients with chest malignancies in anti-tuberculosis hospital].

Autor:	Nekrasov EV; Moscow Research Clinical Center for Tuberculosis Control, Moscow, Russia., Sinitsyn MV; National Medical Research Center for Phthisiopulmonology and Infectious Diseases, Moscow, Russia., Didenko GV; Moscow Research Clinical Center for Tuberculosis Control, Moscow, Russia., Vorobev AA; Moscow Research Clinical Center for Tuberculosis Control, Moscow, Russia., Ivanova DA; Moscow Research Clinical Center for Tuberculosis Control, Moscow, Russia.
Jazyk:	ruština
Zdroj:	Khirurgiia [Khirurgiia (Mosk)] 2023 (7), pp. 12-19.
DOI:	10.17116/hirurgia202307112
Abstrakt:	Objective: To evaluate the effectiveness of surgical treatment of patients with malignancies of lungs, pleura and chest wall in early and long-term follow-up period in anti-tuberculosis hospital. Material and Methods: There were 2139 patients between 2016 and 2020. Chest tumors were diagnosed in 290 (13.6%) patients and 210 (94.2%) ones underwent surgery. Results: Surgical interventions are rare in patients with lung cancer and active tuberculosis (0.7%, n =15). Lobectomies prevailed (73.3%). All sublobar resections were performed in elderly patients with severe comorbidities and low functional reserves. Postoperative complications occurred in 9% of cases. Overall 3-year survival rate was 84.8%, overall 5-year survival rate - 70.8%. Overall survival of patients with lung cancer and tuberculosis does not depend on activity of specific process. Conclusion: The TRA test used in differential diagnostics of tuberculosis and lung cancer has a mediating value. Lung cancer surgery in patients with active tuberculosis has no negative effect on effectiveness of tuberculosis treatment. Surgical treatment of malignancies in anti-tuberculosis hospital can be performed in accordance with standards of specialized medical care in oncology.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu